Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CARS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Lisa Gosselin Chief Commercial Officer | CARS Cars.com Inc. | Sale | 22,888 | $13.25 | $303.3K Sale | Form 4 ↗ |
| Aug 20, 2026 | McGovern Jr. Donald A. Director | CARS Cars.com Inc. | Sale | 8,000 | $12.25 | $98.0K Sale | Form 4 ↗ |
| Aug 17, 2026 | Angelique Strong Marks Chief Legal Officer | CARS Cars.com Inc. | Sale | 57,980 | $11.94 | $692.3K Sale | Form 4 ↗ |
| Jun 12, 2026 | Sonia Jain Chief Financial Officer | CARS Cars.com Inc. | Sale | 34,021 | $9.49 | $322.9K Sale | Form 4 ↗ |
| Jun 11, 2026 | Sonia Jain Chief Financial Officer | CARS Cars.com Inc. | Sale | 52,579 | $9.56 | $502.7K Sale | Form 4 ↗ |
| Mar 13, 2026 | Jenell Ross Director | CARS Cars.com Inc. | Buy | 1,995 | $7.56 | $15.1K Buy | Form 4 ↗ |
| Dec 17, 2025 | Sonia Jain Chief Financial Officer | CARS Cars.com Inc. | Sale | 11,400 | $13.45 | $153.3K Sale | Form 4 ↗ |
| Dec 2, 2025 | Matthew B. Crawford Chief Product Innovation Off. | CARS Cars.com Inc. | Sale | 27,358 | $12.03 | $329.1K Sale | Form 4 ↗ |
| Aug 8, 2025 | Matthew B. Crawford Chief Product Innovation Off. | CARS Cars.com Inc. | Sale | 15,000 | $11.77 | $176.6K Sale | Form 4 ↗ |
| May 9, 2025 | Thomas Alex Vetter CEO, Director | CARS Cars.com Inc. | Buy | 631 | $10.68 | $6,739 Buy | Form 4 ↗ |
| May 9, 2025 | Thomas Alex Vetter CEO, Director | CARS Cars.com Inc. | Buy | 27,239 | $10.75 | $292.8K Buy | Form 4 ↗ |
| Dec 2, 2024 | Jill A. Greenthal Director | CARS Cars.com Inc. | Sale | 10,990 | $19.85 | $218.2K Sale | Form 4 ↗ |
| Nov 27, 2024 | Sonia Jain Chief Financial Officer | CARS Cars.com Inc. | Sale | 25,029 | $19.62 | $491.1K Sale | Form 4 ↗ |
| Nov 26, 2024 | Jill A. Greenthal Director | CARS Cars.com Inc. | Sale | 4,524 | $19.86 | $89.8K Sale | Form 4 ↗ |
| Nov 26, 2024 | Sonia Jain Chief Financial Officer | CARS Cars.com Inc. | Sale | 24,971 | $19.74 | $492.9K Sale | Form 4 ↗ |
| Nov 8, 2024 | Matthew B. Crawford Chief Product Innovation Off. | CARS Cars.com Inc. | Sale | 10,000 | $17.51 | $175.1K Sale | Form 4 ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:32 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances